Gene · 2633
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Meeting report: International Symposium on Mitochondria, Cell Death and Human Diseases: Jawaharlal Nehru University, New Delhi, India, February 18-19, 2023. | Cell Commun Signal | 2023 | 37280623 | PubTator, text mining | PubMed |
| STAT1 is required to establish but not maintain interferon-γ-induced transcriptional memory. | EMBO J | 2023 | 37272165 | PubTator, text mining | PubMed |
| Identification of host regulators of Mycobacterium tuberculosis phenotypes uncovers a role for the MMGT1-GPR156 lipid droplet axis in persistence. | Cell Host Microbe | 2023 | 37269834 | PubTator, text mining | PubMed |
| Intercellular communication involving macrophages at the maternal-fetal interface may be a pivotal mechanism of URSA: a novel discovery from transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | 37265689 | PubTator, text mining | PubMed |
| Mitophagy in atherosclerosis: from mechanism to therapy. | Front Immunol | 2023 | 37261351 | PubTator, text mining | PubMed |
| Itaconate family-based host-directed therapeutics for infections. | Front Immunol | 2023 | 37261340 | PubTator, text mining | PubMed |
| Investigation of Underlying Biological Association and Targets between Rejection of Renal Transplant and Renal Cancer. | Int J Genomics | 2023 | 37261105 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases. | Cell | 2023 | 37236155 | PubTator, text mining | PubMed |
| Chemokine CCL6 Plays Key Role in the Inhibitory Effect of Vitamin A on Norovirus Infection. | J Microbiol | 2023 | 37233907 | PubTator, text mining | PubMed |
| Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity. | Mol Ther Oncolytics | 2023 | 37223114 | PubTator, text mining | PubMed |
| Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. | Mol Biol Rep | 2023 | 37217614 | PubTator, text mining | PubMed |
| The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer. | Heliyon | 2023 | 37215832 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature. | Front Immunol | 2023 | 37205092 | PubTator, text mining | PubMed |
| GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide. | Oncotarget | 2023 | 37204260 | PubTator, text mining | PubMed |
| Proteomic Analysis of Mesenchymal Stem Cells and Monocyte Co-Cultures Exposed to a Bioactive Silica-Based Sol-Gel Coating. | ACS Biomater Sci Eng | 2023 | 37202924 | PubTator, text mining | PubMed |
| Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. | Front Cell Infect Microbiol | 2023 | 37197199 | PubTator, text mining | PubMed |
| GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC. | Int J Gen Med | 2023 | 37193249 | PubTator, text mining | PubMed |
| Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer. | Cancers (Basel) | 2023 | 37190188 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance. | Biomedicines | 2023 | 37189643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2633/papers?page=14